Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 217

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 217
---
 ​ | ​ | ​                                | ​ | 17,500,000 | ​ | ​ | ​ | ​                          | ​ | 17,500,000 | ​ | ​ |
| Pro forma weighted average Class A shares calculation, basic and diluted﻿(1) | ​ | ​ | ​                                    | ​ | 26,774,477 | ​ | ​ | ​ | ​                          | ​ | 26,600,000 | ​ | ​ | ​ | ​                                | ​ | 26,774,477 | ​ | ​ | ​ | ​                          | ​ | 26,600,000 | ​ | ​ |

(1) Number of shares determined based on a price of $10.00 per share. Such price is subject to adjustment based on the five day volume-weighted average price prior to the filing of a resale registration statement covering such shares.

97

TABLE OF CONTENTS

### SPECIAL MEETING OF IRIS STOCKHOLDERS

#### General
We are furnishing this proxy statement/prospectus to our stockholders as part of the solicitation of proxies by the Iris Board for use at the Special Meeting to be held on , 2025, and at any adjournment or postponement thereof. This proxy statement/prospectus is first being furnished to our stockholders on or about , 2025.

#### Date and Time of Special Meeting
The Special Meeting will be held at , Eastern Time, on , 2025, or such other date and time to which such meeting may be adjourned or postponed, for the purposes set forth in the accompanying notice.

The Special Meeting will be a completely virtual meeting of stockholders, which will be conducted via live webcast. You will be able to attend the Special Meeting online, vote and submit your questions during the Special Meeting by visiting . The virtual meeting format allows attendance from any location in the world.

#### Voting Power; Record Date
Iris stockholders of record as of , 2025, the record date for the Special Meeting are entitled to one vote per share of Iris Class A Common Stock at the Special Meeting.

As of the close of business on the record date, there were 7,074,477 shares of Iris Class A Common Stock, 6,900,000 Public Warrants and 5,013,333 Iris Private Placement Warrants to purchase Iris Class A Common Stock outstanding.

#### Vote of Iris’s Sponsor
Pursuant to the Sponsor Agreement, the Sponsor has agreed to, among other things,